KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Divestments (2021 - 2025)

Biogen (BIIB) has 5 years of Divestments data on record, last reported at $56.7 million in Q4 2025.

  • For Q4 2025, Divestments changed N/A year-over-year to $56.7 million; the TTM value through Dec 2025 reached $56.7 million, changed N/A, while the annual FY2025 figure was $56.7 million, 86.06% down from the prior year.
  • Divestments reached $56.7 million in Q4 2025 per BIIB's latest filing, up from -$990.3 million in the prior quarter.
  • Across five years, Divestments topped out at $990.3 million in Q2 2022 and bottomed at -$990.3 million in Q4 2022.
  • Average Divestments over 3 years is $9.4 million, with a median of $14.3 million recorded in 2021.
  • The widest YoY moves for Divestments: up 1669.41% in 2022, down 1669.41% in 2022.
  • A 3-year view of Divestments shows it stood at -$28.1 million in 2021, then plummeted by 3424.2% to -$990.3 million in 2022, then soared by 105.73% to $56.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Divestments were $56.7 million in Q4 2025, -$990.3 million in Q4 2022, and $990.3 million in Q2 2022.